ARCHIVES

Aranesp Improved Anemia In MDS In Phase II Trial

This article is from The Cancer Letter archive.

Vol. 28 No. 9 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

Natcher Subcommittee Kills Recision, Save NCI $17 Million

May 2, 1980

White House Appoints Slamon To Cancer Panel; Brinker To Address Republican Convention.

July 28, 2000

Elm {15 for 17} Has Some Advice For Would Be CCOPs

July 18, 1986

New Phase III Follow-Up Data of Yervoy Trial Shows 19 Percent Survival at Four Years

October 26, 2012

DCPTC Proceeding With Plans For Intramural Lab

January 30, 1987

FDA News: ODAC Clears Photofrin For Microinvasive NSCLC

September 26, 1997